Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21396779 | 0.92 | LRRK2 (0.34) | SMN1; SMN2HIF1ALRRK2SLC22A12PDE4B | |
| SCHEMBL21397150 | 0.88 | SMN1; SMN2 (0.36) | SMN1; SMN2HIF1ACYP11B2LRRK2SLC22A12 | |
| SCHEMBL19755260 | 0.86 | SMN1; SMN2 (0.43) | SMN1; SMN2HIF1A | |
| SCHEMBL21396660 | 0.85 | CYP11B2 (0.33) | SMN1; SMN2HIF1ACYP11B2LRRK2SLC22A12 | |
| SCHEMBL22377480 | 0.84 | SMN1; SMN2 (0.42) | SMN1; SMN2HIF1A | |
| SCHEMBL21397052 | 0.83 | KDM4E (0.35) | SMN1; SMN2HIF1ACYP11B2 | |
| SCHEMBL21396741 | 0.83 | TGFBR1 (0.39) | — | |
| SCHEMBL21396787 | 0.81 | TDO2 (0.33) | — | |
| SCHEMBL21396907 | 0.81 | DDB1 (0.34) | SMN1; SMN2CYP11B2RECQL | |
| SCHEMBL19755216 | 0.80 | IMPDH2 (0.38) | SMN1; SMN2HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190296247-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLC25A21, SLCO4C1, SLC18A1 | SMN1; SMN2 3762/4885HIF1A 3513/4885CYP11B2 1859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.